Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Rallybio Corp
RLYB

Buy Rallybio Corp (RLYB) Stock

RLYB
See RLYB stock price and Buy/Sell Rallybio Corp with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
RLYB

Rallybio Corp (RLYB)

About Rallybio Corp (RLYB)

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is...Read more
Market Cap
$430.25M
1 Year High
$21
Volume
25.02k
1 Year Low
$5.90
Price to Earnings Ratio
Open
$13.45
Dividend Rate
High
$14.46
Dividend Yield
Low
$13.06

Community

People who own or watch RLYB stock

Rallybio Corp Price Targets

What analysts think RLYB stock price will be.
$13.48
$30.50
126.3% Upside
$5$33

Rallybio Corp Stock Rating

What analysts recommend for RLYB stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

Rallybio Corp Stock Earnings

The value each RLYB share was expected to gain vs. the value that each RLYB share actually gained.
Expected
Actual

Rallybio Corp Stock News

Frequently Asked Questions (FAQ)

As of Sep 27, 2022, the market cap for RLYB stock is $430.25M

The 52-week high for RLYB stock is $21. The current RLYB stock price $13.48 is 35.81% below its 52-week high

The 52-week low for RLYB stock is $5.90. The current RLYB stock price $13.48 has increased 56.23% from its 52-week low

No, the RLYB stock does not pay dividends to its shareholders

The target price for RLYB stock is $30.50 based on the average of what a group of analyst think RLYB stock could be worth at a future date. This is not a prediction by Public.com

Buy Rallybio Corp (RLYB) Stock

RLYB
See RLYB stock price and Buy/Sell Rallybio Corp with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch RLYB stock
  • BYF avatar
  • WSpicher avatar
  • easuncion77 avatar
  • Capone_D avatar
  • cyartchick avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.